ReviewCancer immunology, immunotherapy : CII2004

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination.

Pedro Romero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.